Pregnancy Labeling: FDA Should Follow EMEA’s Lead On Classification, Firms Say
Executive Summary
FDA should adopt the European Medicines Agency's categorizations of pregnancy risk information in labeling, industry recommends in comments on the agency's proposed rule
You may also be interested in...
Pregnancy Registries Should Not Be Mandated In Drug Label, Amgen Tells FDA
Industry is challenging one of the central components of FDA's proposed rule on pregnancy and lactation labeling - that any existing registries for patients should be included in labeling
Pregnancy Registries Should Not Be Mandated In Drug Label, Amgen Tells FDA
Industry is challenging one of the central components of FDA's proposed rule on pregnancy and lactation labeling - that any existing registries for patients should be included in labeling
FDA “Xes” Letter Categories For Pregnancy Labels; Data Collection Drives Reg
FDA's proposed rule to update the format of the pregnancy and lactation sections of drug labeling does not require the firms collect new data about their products, but the agency is hoping to use various mechanisms to encourage them to do so